23 related articles for article (PubMed ID: 35177497)
1. [Not Available].
Doleeb Z; Tesfaye M; Selk A; Dunn S; Maxwell C
Can Fam Physician; 2022 Feb; 68(2):99-102. PubMed ID: 35177497
[No Abstract] [Full Text] [Related]
2. At-home HIV self-testing during COVID: implementing the GetaKit project in Ottawa.
O'Byrne P; Musten A; Orser L; Inamdar G; Grayson MO; Jones C; Francoeur M; Lachance S; Paulin V
Can J Public Health; 2021 Aug; 112(4):587-594. PubMed ID: 33999399
[TBL] [Abstract][Full Text] [Related]
3. The impact of the COVID-19 pandemic on the Ontario Cervical Screening Program, colposcopy and treatment services in Ontario, Canada: a population-based study.
Meggetto O; Jembere N; Gao J; Walker MJ; Rey M; Rabeneck L; Murphy KJ; Kupets R;
BJOG; 2021 Aug; 128(9):1503-1510. PubMed ID: 33982870
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness studies of HPV self-sampling: A systematic review.
Malone C; Barnabas RV; Buist DSM; Tiro JA; Winer RL
Prev Med; 2020 Mar; 132():105953. PubMed ID: 31911163
[TBL] [Abstract][Full Text] [Related]
5. Cancer screening rates among transgender adults: Cross-sectional analysis of primary care data.
Kiran T; Davie S; Singh D; Hranilovic S; Pinto AD; Abramovich A; Lofters A
Can Fam Physician; 2019 Jan; 65(1):e30-e37. PubMed ID: 30674526
[TBL] [Abstract][Full Text] [Related]
6. Cervical cancer.
Cohen PA; Jhingran A; Oaknin A; Denny L
Lancet; 2019 Jan; 393(10167):169-182. PubMed ID: 30638582
[TBL] [Abstract][Full Text] [Related]
7. Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses.
Arbyn M; Smith SB; Temin S; Sultana F; Castle P;
BMJ; 2018 Dec; 363():k4823. PubMed ID: 30518635
[TBL] [Abstract][Full Text] [Related]
8. Barriers to cervical cancer screening faced by immigrant women in Canada: a systematic scoping review.
Ferdous M; Lee S; Goopy S; Yang H; Rumana N; Abedin T; Turin TC
BMC Womens Health; 2018 Oct; 18(1):165. PubMed ID: 30305056
[TBL] [Abstract][Full Text] [Related]
9. Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months: The HPV FOCAL Randomized Clinical Trial.
Ogilvie GS; van Niekerk D; Krajden M; Smith LW; Cook D; Gondara L; Ceballos K; Quinlan D; Lee M; Martin RE; Gentile L; Peacock S; Stuart GCE; Franco EL; Coldman AJ
JAMA; 2018 Jul; 320(1):43-52. PubMed ID: 29971397
[TBL] [Abstract][Full Text] [Related]
10. Self-Sampling for Human Papillomavirus Testing: Increased Cervical Cancer Screening Participation and Incorporation in International Screening Programs.
Gupta S; Palmer C; Bik EM; Cardenas JP; Nuñez H; Kraal L; Bird SW; Bowers J; Smith A; Walton NA; Goddard AD; Almonacid DE; Zneimer S; Richman J; Apte ZS
Front Public Health; 2018; 6():77. PubMed ID: 29686981
[TBL] [Abstract][Full Text] [Related]
11. Test performance and acceptability of self- versus provider-collected swabs for high-risk HPV DNA testing in female-to-male trans masculine patients.
Reisner SL; Deutsch MB; Peitzmeier SM; White Hughto JM; Cavanaugh TP; Pardee DJ; McLean SA; Panther LA; Gelman M; Mimiaga MJ; Potter JE
PLoS One; 2018; 13(3):e0190172. PubMed ID: 29538411
[TBL] [Abstract][Full Text] [Related]
12. Cytology versus HPV testing for cervical cancer screening in the general population.
Koliopoulos G; Nyaga VN; Santesso N; Bryant A; Martin-Hirsch PP; Mustafa RA; Schünemann H; Paraskevaidis E; Arbyn M
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD008587. PubMed ID: 28796882
[TBL] [Abstract][Full Text] [Related]
13. The Effect of Changes in Cervical Cancer Screening Guidelines on Chlamydia Testing.
Naimer MS; Kwong JC; Bhatia D; Moineddin R; Whelan M; Campitelli MA; Macdonald L; Lofters A; Tuite A; Bogler T; Permaul JA; McIsaac WJ
Ann Fam Med; 2017 Jul; 15(4):329-334. PubMed ID: 28694268
[TBL] [Abstract][Full Text] [Related]
14. Optimizing secondary prevention of cervical cancer: Recent advances and future challenges.
Ogilvie G; Nakisige C; Huh WK; Mehrotra R; Franco EL; Jeronimo J
Int J Gynaecol Obstet; 2017 Jul; 138 Suppl 1():15-19. PubMed ID: 28691338
[TBL] [Abstract][Full Text] [Related]
15. Clinician and Patient Acceptability of Self-Collected Human Papillomavirus Testing for Cervical Cancer Screening.
Mao C; Kulasingam SL; Whitham HK; Hawes SE; Lin J; Kiviat NB
J Womens Health (Larchmt); 2017 Jun; 26(6):609-615. PubMed ID: 28332888
[TBL] [Abstract][Full Text] [Related]
16. Cost-Effectiveness of Primary HPV Testing, Cytology and Co-testing as Cervical Cancer Screening for Women Above Age 30 Years.
Jin XW; Lipold L; Foucher J; Sikon A; Brainard J; Belinson J; Schramm S; Nottingham K; Hu B; Rothberg MB
J Gen Intern Med; 2016 Nov; 31(11):1338-1344. PubMed ID: 27418345
[TBL] [Abstract][Full Text] [Related]
17. A qualitative study of provider perspectives of structural barriers to cervical cancer screening among first nations women.
Maar M; Burchell A; Little J; Ogilvie G; Severini A; Yang JM; Zehbe I
Womens Health Issues; 2013; 23(5):e319-25. PubMed ID: 23993479
[TBL] [Abstract][Full Text] [Related]
18. Recommendations on screening for cervical cancer.
Dickinson J; Tsakonas E; Conner Gorber S; Lewin G; Shaw E; Singh H; Joffres M; Birtwhistle R; Tonelli M; Mai V; McLachlin M;
CMAJ; 2013 Jan; 185(1):35-45. PubMed ID: 23297138
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
